Your browser doesn't support javascript.
loading
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha, Anna; Kahya, Ugur; Linge, Annett; Chen, Oleg; Löck, Steffen; Lukiyanchuk, Vasyl; Richter, Susan; Alves, Tiago C; Peitzsch, Mirko; Telychko, Vladyslav; Skvortsov, Sergej; Negro, Giulia; Aschenbrenner, Bertram; Skvortsova, Ira-Ida; Mirtschink, Peter; Lohaus, Fabian; Hölscher, Tobias; Neubauer, Hans; Rivandi, Mahdi; Labitzky, Vera; Lange, Tobias; Franken, André; Behrens, Bianca; Stoecklein, Nikolas H; Toma, Marieta; Sommer, Ulrich; Zschaeck, Sebastian; Rehm, Maximilian; Eisenhofer, Graeme; Schwager, Christian; Abdollahi, Amir; Groeben, Christer; Kunz-Schughart, Leoni A; Baretton, Gustavo B; Baumann, Michael; Krause, Mechthild; Peitzsch, Claudia; Dubrovska, Anna.
Afiliação
  • Mukha A; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Kahya U; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Dresden, Germany.
  • Linge A; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Chen O; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Dresden, Germany.
  • Löck S; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Lukiyanchuk V; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.
  • Richter S; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Alves TC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Peitzsch M; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany.
  • Telychko V; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Skvortsov S; Department of Cell Signaling, Institute of Cell Biology, NAS of Ukraine, Lviv, Ukraine.
  • Negro G; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Aschenbrenner B; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.
  • Skvortsova II; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mirtschink P; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Lohaus F; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Hölscher T; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Dresden, Germany.
  • Neubauer H; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Rivandi M; Department for Clinical Pathobiochemistry, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Labitzky V; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Lange T; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Franken A; Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
  • Behrens B; EXTRO-Lab, Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Stoecklein NH; Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
  • Toma M; EXTRO-Lab, Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Sommer U; Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
  • Zschaeck S; EXTRO-Lab, Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Rehm M; Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
  • Eisenhofer G; EXTRO-Lab, Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Schwager C; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Abdollahi A; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Groeben C; German Cancer Consortium (DKTK), Partner Site Dresden, Germany.
  • Kunz-Schughart LA; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Baretton GB; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Baumann M; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Germany.
  • Krause M; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
  • Peitzsch C; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany.
  • Dubrovska A; Department of Obstetrics and Gynecology, Medical Faculty and University Hospital of the Heinrich-Heine University Düsseldorf, Germany.
Theranostics ; 11(16): 7844-7868, 2021.
Article em En | MEDLINE | ID: mdl-34335968
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Tolerância a Radiação / Glutamina Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Theranostics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Tolerância a Radiação / Glutamina Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Theranostics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha